# Lantheus Holdings

Type: Company (LNTH)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/lantheus-holdings
Canonical HTML page: https://gethealthbrief.com/entity/lantheus-holdings

## Recent coverage (3 stories)

### Mid-Cap Biotech Earnings: Specialized Platforms Outperform in Q4 2025
2026-02-26 22:32:06 · Sentiment: Neutral · Impact: 5/10 · Sources: 12

The Q4 2025 earnings cycle for mid-cap healthcare highlights a strategic shift from clinical validation to commercial execution across gene editing, radiopharmaceuticals, and digital health. While platform innovators like Intellia and Kymera advance toward pivotal milestones, commercial leaders like Lantheus and Vericel are demonstrating the durability of high-barrier therapeutic markets.
Full story: https://gethealthbrief.com/story/mid-cap-biotech-q4-2025-earnings-intelligence

### Lantheus and Heron Signal Long-Term Growth Amid Mixed Q4 Performance
2026-02-26 13:15:01 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Lantheus Holdings and Heron Therapeutics both reported mixed fourth-quarter results for the 2025 fiscal year, balancing immediate commercial headwinds with aggressive long-term guidance. Both companies introduced fiscal year 2026 outlooks, signaling a strategic shift toward post-2025 growth catalysts and pipeline diversification.
Full story: https://gethealthbrief.com/story/lantheus-heron-q4-earnings-fy26-outlook

### MedTech and Specialty Pharma Braced for High-Stakes Q4 2025 Results
2026-02-25 15:05:48 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Delcath Systems, Lantheus Holdings, Butterfly Network, and Heron Therapeutics are preparing to report Q4 2025 earnings, marking a critical test for commercial-stage medical innovators. Investors are laser-focused on the adoption rates of flagship products like HEPZATO KIT and PYLARIFY as these companies navigate a complex reimbursement environment.
Full story: https://gethealthbrief.com/story/medtech-specialty-pharma-q4-2025-earnings-preview

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.